Immediate implant placement, with the advantages of placing the implant during the same visit as tooth extraction and shortening the restoration cycle, is attracting more and more attention from edentulous people. However, many middle-aged and elderly patients have long-standing concerns—believing that imported implant solutions are expensive and have strict requirements for alveolar bone conditions. As a German-registered brand, OsseoBio is precisely based on this real demand, taking the bone characteristics of the Asian population as its R&D baseline and cost-effectiveness as its path, to provide clinicians and patients with more suitable immediate restoration options.

We have noticed that many European and American implant systems entering the domestic market are mostly developed based on the broad jaw structure and sufficient bone density of European and American populations. However, Asian populations generally have narrower dental arches and lower bone density, and osteoporosis is even more common among middle-aged and elderly groups—generic implants often have limitations in adaptability.

OsseoBio was founded in Berlin, Germany, and its Asian production base is located in Busan, South Korea. We bring together European and Asian R&D experts, focusing on developing implants that adapt to different bone conditions, especially committed to finding a better fit for Asian faces. The signature “waist-like” narrowed neck design effectively reduces cortical bone stress and maintains long-term stability of bone and soft tissues; the large thread structure has deep bone engagement and can achieve high primary stability, especially suitable for half-arch and full-arch immediate implant placement.

In terms of the restoration cycle, the product structure is compatible with immediate implant placement operating standards; tooth extraction, implant placement, and placement of a provisional tooth can be completed in the same session. In terms of surgical experience, the minimally invasive refined body reduces bone removal and lowers postoperative swelling and pain. In terms of price, under the same process standards, it is more affordable and cost-effective than first-tier high-end European and American brands.

In addition to product R&D, we continue to expand the domestic medical market and regularly organize standardized training for primary-care implant dentists, uniformly explaining standardized operating procedures for immediate and minimally invasive implant placement. In the face of complex cases such as narrow bone and porous/osteoporotic bone, OsseoBio   shows stable surgical success rates, greatly lowering the technical threshold for primary-level institutions to carry out immediate implant placement, so that edentulous people do not need to travel specifically to first-tier cities and can complete restoration at local regular dental clinics.

From the laboratory to localized improvement based on combined Chinese and Korean clinical data, and then to coverage of dental clinics at all levels in China—OsseoBio, with a German-standard Korean manufacturing model, balances surgical outcomes, patient experience, and restoration cost. It is a reliable choice for cost-effective imported immediate implant restoration.